AC
TMO icon

AlphaCore Capital’s Thermo Fisher Scientific TMO Stock Holding History

AlphaCore Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.06M Buy
10,091
+7,328
+265% +$3.52M 0.09% 186
2026
Q1 		$1.36M Sell
2,763
-152
-5% -$82.5K 0.03% 317
2025
Q4 		$1.69M Buy
2,915
+118
+4% +$66.7K 0.04% 304
2025
Q3 		$1.36M Sell
2,797
-1,338
-32% -$623K 0.05% 242
2025
Q2 		$1.68M Sell
4,135
-1,431
-26% -$598K 0.06% 199
2025
Q1 		$2.77M Buy
5,566
+3,940
+242% +$2.13M 0.24% 88
2024
Q4 		$846K Buy
1,626
+1,276
+365% +$702K 0.18% 89
2024
Q3 		$217K Buy
+350
New +$207K 0.05% 187

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

AlphaCore Capital's TMO Position: Q2 2026 in Review

AlphaCore Capital increased its Thermo Fisher Scientific (TMO) stake by 265% in Q2 2026, buying an estimated $3.52M and bringing the position to 10,091 shares worth $5.06M. The position accounts for 0.09% of the portfolio, ranked #186.

AlphaCore Capital first reported a position in TMO in Q3 2024 and has held it in 8 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • AlphaCore Capital held 10,091 shares of Thermo Fisher Scientific worth $5.06M as of Q2 2026.
  • AlphaCore Capital bought 7,328 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.52M.
  • Thermo Fisher Scientific made up 0.09% of AlphaCore Capital's portfolio in Q2 2026, its #186 holding.
  • AlphaCore Capital first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 8 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.